75N98026R00176_Coordination_Center_Notice_of_Intent_2.pdf

Non-competitive Notice of Intent Synopsis

Type: Special Notice Notice Number: 75N98026R00176 Title: National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation Funnel Coordination Center Classification Code: A – Research & Development NAICS Code: 541614 - Process, Physical Distribution and Logistics Consulting Services Posted Date: October 16, 2026 Response Date: November 2, 2026 Primary Point of Contact: Melanie Suarez, Contracting Officer, melanie.suarez@nih.gov

INTRODUCTION

THIS SYNOPSIS IS A NON-COMPETITIVE NOTICE OF INTENT TO AWARD A MODIFICATION TO

INCREASE THE INDEFINITE-DELIVERY/INDEFINITE-QUANTITY (IDIQ) CEILING OF CONTRACT NO.

75N92022D00014 WITHOUT PROVIDING FOR FULL AND OPEN COMPETITION (INCLUDING

BRAND-NAME).

This acquisition is conducted under the authority of 41 United States Code (U.S.C.) 3304(a)(1), as set forth in RFO – Federal Acquisition Regulation (FAR) 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements.

The National Institute of Biomedical, Imaging, and Bioengineering (NIBIB) intends to award a modification to Indefinite-Delivery/Indefinite-Quantity (IDIQ) Contract No. 75N92022D00014, facilitating the requirements of the Rapid Acceleration of Diagnostics (RADx-Tech) initiative, an innovation funnel aimed at increasing the speed of development, commercialization, and implementation of health technologies, without providing for full and open competition (including brand-name) to the Massachusetts General Hospital Consortia for Improving Medicine with Innovation and Technology (CIMIT). The IDIQ ceiling value for Contract No.

75N92022D00014 will be increased through a modification action to accommodate and to continue core operational activities outlined in the Statement of Work (SOW). It is anticipated that the modification will be issued around December 2026. THIS IS A SYNOPSIS. THIS IS NOT A

SOLICITATION.

BACKGROUND AND PROGRAM OBJECTIVES

In response to the COVID-19 pandemic, the NIBIB created the Rapid Acceleration of Diagnostics (RADx-Tech) initiative, an innovation funnel aimed at increasing the speed of development, commercialization, and implementation of technologies for COVID-19 testing. The RADx-Tech innovation funnel was designed to compress the customary technology development timeline from years down to just months. This was accomplished by employing, in parallel, expert teams of contracted consultants to assist technology developers in addressing technical, regulatory, clinical, and commercialization requirements. It is envisioned that further acceleration of healthcare innovations will enable greater preparedness for future pandemics, as well as provide significant advances to the current healthcare paradigm across a broad range of clinical indications. In an effort to leverage the RADx-Tech model for rapid acceleration of innovative mailto:melanie.suarez@nih.gov technologies, the NIBIB requires highly specialized and uniquely experience contracted personnel capable of proving critical project, program, and portfolio support.

The innovation funnel has been structured as a collaborative network of centers that each serve critical roles in accelerating technology development progress. The three centers, Coordination Center, Commercialization Center, and Validation Center, will be required to communicate and interact routinely within the various innovation funnel processes. The Coordination Center will be responsible for overall operational oversight and guidance, ensuring standard operating procedures and streamlined workflows for project review and management. The Commercialization Center will be responsible for identifying and selecting subject matter experts who will support the innovation funnel processes, such as project review, project management, and commercialization assistance. The Coordination Center and Commercialization Center partner closely to determine expertise gaps and fill needs as appropriate. The Validation Center will be responsible for providing technical and clinical validation services, verifying progress of prototype technologies against key performance and design metrics. The Validation Center will harmonize services with the workflows from the Coordination Center and the experts of the Commercialization Center. Working in concert, the three innovation funnel centers enable parallel efforts that greatly increase the efficiency of the funnel.

The objective of this requirement is to provide product commercialization expertise and resources to various NIH translational activities.

PROJECT REQUIREMENTS

Indefinite Delivery-Indefinite Quantity (IDIQ) contract 75N92022D00014 is for a single vendor that requires specialized and comprehensive strategic, technical, and operational levels of support for NIH translational activities. Critical to the governance and implementation of complex funding initiatives is centralized coordination of processes, workflows, and resources.

The Coordination Center is responsible for all day-to-day activities including communication and scheduling, application solicitation, electronic application submission, data management, application evaluation, project management, website management, technical and business support, coordination of clinical and commercialization resources, drafting standard operating procedures, and delivering progress reports.

Continued synchronization of all aspects of this IDIQ is important for successful completion of the program.

CLOSING STATEMENT

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties bona-fide capabilities for fulfilling the requirement, addressing each project requirement separately. The response should also include: 1) the total number of employees; 2) the professional qualifications of scientists, medical experts, and technical personnel as it relates to the above outlined requirements; 3) a description of general and specific facilities and equipment available, including computer equipment and software; 4) an outline of previous research projects that are similar to the project requirements in which the organization and proposed personnel have participated; and 5) any other information considered relevant to this program. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

A determination by the Government not to compete this proposed contract modification action based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses must be received by the closing date on this notice and must reference the solicitation number. Responses may be submitted electronically in accordance with the instructions below.

“All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”

Submission Instructions:

Interested parties shall submit capability statements via electronic mail and must reference the Notice number 75N98026R00176 in the subject line of the e-mail submission.

The due date for receipt of responses is 12:00 p.m. Eastern Standard Time (EST) on November 2, 2026. All responses must be received by the specified due date and time in order to be considered.

Capability responses shall be submitted electronically to the designated Contracting Officer and Contract Specialist as follows:

http://www.sam.gov/

Melanie Suarez, Contracting Officer: melanie.suarez@nih.gov Noelle Decenzo, Contract Specialist: noelle.decenzo@nih.gov

This notice does not obligate the Government to award a contract(s) or otherwise pay for the information provided in the response. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted.

mailto:melanie.suarez@nih.gov mailto:noelle.decenzo@nih.gov